Lubner David Charles

Director at ACLX; SVP and CFO at TETRAPHASE PHARMACEUTICALS INC

Sold, on record
$3M
Dollars the filings state
Form 4 sales
9
Latest Jan 20, 2026
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

1
Routine
7
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale TETRAPHASE PHARMACEUTICALS INCPlan not stated
    Mar 6, 2014 2014

    Sold 4,510 shares at $13.65 ($62k)

    Lubner David Charles, SVP and CFO

    Sold 4.7% of holdings ($1.3M position)91,993 shares leftFiling

  2. 2 Form 4 sale TETRAPHASE PHARMACEUTICALS INCUnusual
    Jun 17, 2014 +103 days

    Sold 13,530 shares at $12.51 ($169k)

    Lubner David Charles, SVP and CFO

    Sold 14.7% of holdings ($1.2M position)78,463 shares left3x usual sizeFiling

  3. 3 Form 4 sale TETRAPHASE PHARMACEUTICALS INCPlan not stated
    May 14, 2015 +331 days

    Sold 15,000 shares at $39.28 ($589k)

    Lubner David Charles, SVP and CFO

    Sold 15.9% of holdings ($3.7M position)79,270 shares left2.1x usual sizeFiling

  4. 4 Form 4 sale TETRAPHASE PHARMACEUTICALS INCPlan not stated
    Jun 15, 2015 +32 days

    Sold 17,500 shares at $41.45 ($725k)

    Lubner David Charles, SVP and CFO

    Sold 20.2% of holdings ($3.6M position)69,270 shares left1.8x usual sizeFiling

  5. 5 Form 4 sale TETRAPHASE PHARMACEUTICALS INCPlan not stated
    Jul 14, 2015 +29 days

    Sold 7,500 shares at $48.92 ($367k)

    Lubner David Charles, SVP and CFO

    Sold 9.8% of holdings ($3.8M position)69,270 shares left0.6x usual sizeFiling

  6. 6 Form 4 sale TETRAPHASE PHARMACEUTICALS INCPlan not stated
    Aug 14, 2015 +31 days

    Sold 9,500 shares at $42.92 ($408k)

    Lubner David Charles, SVP and CFO

    Sold 12.1% of holdings ($3.4M position)69,270 shares left1x usual sizeFiling

  7. 7 Form 4 sale ACLXRoutine
    Jan 20, 2026 +3812 days

    Sold 6,000 shares at $75.00 ($450k)

    Lubner David Charles, Director

    10b5-1 planSold 21.7% of holdings ($2.1M position)21,659 shares leftFirst sale on recordFollows a Form 144Filing

  8. 8 Form 144 notice ACLXNotice
    Jan 20, 2026 same day

    Filed to sell 15,000 shares ($1M)

    Lubner David Charles, Director

    10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Lubner David Charles
Source
Jan 20, 2026Jan 20, 2026ACLXDirectorForm 144 notice15,000$1MNoticeSEC
Jan 20, 2026Jan 20, 2026ACLXDirectorForm 4 sale6,000$450k21.7%RoutineSEC
Aug 14, 2015Aug 17, 2015TETRAPHASE PHARMACEUTICALS INCSVP and CFOForm 4 sale9,500$408k12.1%Plan not statedSEC
Jul 14, 2015Jul 15, 2015TETRAPHASE PHARMACEUTICALS INCSVP and CFOForm 4 sale7,500$367k9.8%Plan not statedSEC
Jun 15, 2015Jun 16, 2015TETRAPHASE PHARMACEUTICALS INCSVP and CFOForm 4 sale17,500$725k20.2%Plan not statedSEC
May 14, 2015May 18, 2015TETRAPHASE PHARMACEUTICALS INCSVP and CFOForm 4 sale15,000$589k15.9%Plan not statedSEC
Jun 17, 2014Jun 18, 2014TETRAPHASE PHARMACEUTICALS INCSVP and CFOForm 4 sale13,530$169k14.7%UnusualSEC
Mar 6, 2014Mar 10, 2014TETRAPHASE PHARMACEUTICALS INCSVP and CFOForm 4 sale4,510$62k4.7%Plan not statedSEC
Feb 12, 2014Feb 13, 2014TETRAPHASE PHARMACEUTICALS INCSVP and CFOForm 4 sale4,506$63k4.5%Plan not statedSEC
Feb 7, 2014Feb 11, 2014TETRAPHASE PHARMACEUTICALS INCSVP and CFOForm 4 sale9,928$141k8.9%Plan not statedSEC